Value of the uCyt+™ test for the detection and follow-up of bladder tumours;Intérêt du test uCyt+™ pour le dépistage et le suivi des tumeurs de vessie

Progres en Urologie

Volumn 13, Issue 2, 2003, Pages 222-226

  Drapier, Eric ^a   Renaudin, Karine ^a   Maillet, Frédéric ^a   Braud, Guillaume ^a   Laboisse, Christian ^a   Bouchot, Olivier ^a  

^a HÔTEL DIEU   (France)

Author keywords

Cytology; Screening; Superficial bladder tumour

Indexed keywords

CANCER ANTIBODY;

AGED; ARTICLE; BLADDER TUMOR; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; LITERATURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROSPECTIVE STUDY; TUMOR CELL; URINE CYTOLOGY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; URINE;

CYSTOSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE;

EID: 0043211064     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. ALLARD P., FRADET Y., TETU B., BERNARD P. : Tumor-associated antigens as prognostic factors in recurrence in 382 patients with primary transitional cell carcinoma of the bladder. Clin. Cancer Res., 1995.
2. BERGER A., PARSON W., STENZL A., STEINER H., BARTSCH G., KLOCKER H. : Microsatellite alterations in human bladder cancer : detection of tumor cells in urine sediment and tumor tissue. Eur. Urol., 2002 ; 41 : 532-539.
3. CLARK K., HIGGS M. : Urinary infection following out-patient flexible cystoscopy. Br. J. Urol., 1990 ; 66 : 503-505.
4. FRADET Y., ISLAM N., BOUCHER L., PARENT-VAUGEOIS C., TARDIF M. : Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies. Proc. Natl. Acad. Sci., 1987 ; 84 : 7227-7231.
5. FRADET Y., LARUE H., PARENT-VAUGEOIS C., BERGERON A., DUFOUR C., BOUCHER L., BERNIER L. : Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas. Int. J. Cancer, 1990; 46: 990-997.
6. FRADET Y., LOCKHART C., EMOND J., ZADRA J., JEWETT M., BERTRAND P., HOULE J., SCHICK E., BARKIN J., BELL D., CORCOS J., TRUDEL C., CHIN J., CASEY R., SHORT T., SAAD F., VEZINA J., PARENT C., DESAULNIERS M. : Performance characteristics of a new monoclonal antibody test for bladder cancer : Immunocyt. Canad. J. Urol., 1997 ; 4 : 400-405.
7. FRADET Y., VELTRI R., SIMARD P., BLUMENSTEIN B., O'DOWD G. : Improved detection of bladder cancer by immunocytology with monoclonal antobodies M344 and 19A211. Canadian Urological Association Meeting, 1996 ; 29.
8. FRADET Y. G.J., BEDARD G .: Monitoring and prognostic determination of bladder tumors by flow cytometry with monoclonal antibodies on bladder irrigations. J. Urol., 1991 ; 145 : 250.
9. LOCKHART C., PARENT C., DESAULNIERS M., DUBE L., FRADET Y. : Evaluation of a monoclonal antibody test for the detection of superficial bladder cancer : ImmunoCyt. J. Urol., 1998 ; 159 : 243.
10. LUGAGNE P., HERVE J., LEBRET T., GAUDEZ F., BARRE P., BOTTO H. : Risques infectieux de la fibroscopie urétro-vésicale en ambulatoire chez l'homme à urines stériles. Prog. Urol., 1997 ; 7 : 615-617.
11. MANSON A. : Is antibiotic administration indicated after outpatient cystoscopy ? J. Urol., 1988 ; 140 : 316-317.
12. MENEGOZ F., al. : Cancer incidence and mortality in France in 1975-1995. Eur. J. Cancer Prev., 1997 ; 6 : 442-466.
13. MIAN C., PYCHA A., WIENER H., HAITEL A., LODDE M., MARBERGER M. : ImmunoCyt : a new tool for detecting transitional cell cancer of the urinary tract. J. Urol., 1999 ; 161 : 1486-1489.
14. NEVES M., CIOFU C., LAROUSSERIE F., FLEURY J., SIBONY M., FLAHAULT A., SOUBRIER F., GATTEGNO B. : Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection. J. Urol., 2002 ; 167 : 1276-1281.
15. PAPANICOLAOU G., MARSHALL V. : Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science, 1945 ; 101 : 519-520.
16. PODE D., GOLIJANIN D., SHERMAN Y., LEBENSART P., SHAPIRO A. : Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors. J. Urol., 1998 ; 159 : 389-393.
17. SCHNEIDER A., BORGNAT S., LANG H., REGINE O., LINDNER V., KASSEM M., SAUSSINE C., OUDET P., JACQMIN D., GAUB M. : Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res., 2000 ; 60 : 4617-4622.
18. STAMPFER D., CARPINITO G., RODRIGUEZ-VILLANUEVA J., WILLSEY L., DINNEY C., GROSSMAN H., FRITSCHE H., McDOUGAL W. : Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J. Urol., 1998 ; 159 : 394-398.
19. WIENER H., MIAN C., HAITEL A., PYCHA A., SCHATZL G., MARBERGER M. : Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer ? J. Urol., 1998 ; 159: 1876-1880.